COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

doi:10.1016/j.jaip.2022.01.037

. 2022 May;10(5):1377-1379.

doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

Nikolaos Lazarinis¹, Apostolos Bossios¹, Theo Gülen²

Affiliations

¹ Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
² Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska Institutet and Karolinska University, Hospital Huddinge, Stockholm, Sweden. Electronic address: theo.gulen@regionstockholm.se.

PMID: 35123098
PMCID: PMC8810433
DOI: 10.1016/j.jaip.2022.01.037

Free PMC article

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

Nikolaos Lazarinis et al. J Allergy Clin Immunol Pract. 2022 May.

Free PMC article

. 2022 May;10(5):1377-1379.

doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.

Authors

Nikolaos Lazarinis¹, Apostolos Bossios¹, Theo Gülen²

Affiliations

¹ Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
² Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska Institutet and Karolinska University, Hospital Huddinge, Stockholm, Sweden. Electronic address: theo.gulen@regionstockholm.se.

PMID: 35123098
PMCID: PMC8810433
DOI: 10.1016/j.jaip.2022.01.037

No abstract available

PubMed Disclaimer

Cited by

Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.
Giannetti MP, Nicoloro-SantaBarbara J, Godwin G, Middlesworth J, Espeland A, Douvas JL, Castells MC. Giannetti MP, et al. Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123. Diagnostics (Basel). 2024. PMID: 38247999 Free PMC article. Review.
COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma.
Bossios A, Bacon AM, Eger K, Paróczai D, Schleich F, Hanon S, Sergejeva S, Zervas E, Katsoulis K, Aggelopoulou C, Kostikas K, Gaki E, Rovina N, Csoma Z, Grisle I, Bieksiené K, Palacionyte J, Ten Brinke A, Hashimoto S, Mihălţan F, Nenasheva N, Zvezdin B, Čekerevac I, Hromiš S, Ćupurdija V, Lazic Z, Chaudhuri R, Smith SJ, Rupani H, Haitchi HM, Kurukulaaratchy R, Fulton O, Frankemölle B, Howarth P, Porsbjerg C, Bel EH, Djukanovic R, Hyland ME. Bossios A, et al. ERJ Open Res. 2023 Nov 27;9(6):00590-2023. doi: 10.1183/23120541.00590-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 38020570 Free PMC article.
SARS-CoV-2 and allergy - what have we learned after two and a half years?
Brockow K, Wang R, Mathes S, Bent R, Faihs V, Eberlein B, Darsow U, Biedermann T. Brockow K, et al. Allergol Select. 2023 Mar 31;7:101-112. doi: 10.5414/ALX02373E. eCollection 2023. Allergol Select. 2023. PMID: 37056446 Free PMC article. Review.
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study.
Bonadonna P, Olivieri F, Jarkvist J, Nalin F, Zanotti R, Maclachlan L, Gülen T. Bonadonna P, et al. Front Allergy. 2022 Dec 5;3:1071807. doi: 10.3389/falgy.2022.1071807. eCollection 2022. Front Allergy. 2022. PMID: 36545345 Free PMC article.
The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.
Khalid MB, Frischmeyer-Guerrerio PA. Khalid MB, et al. J Allergy Clin Immunol Glob. 2023 Feb;2(1):1-13. doi: 10.1016/j.jacig.2022.10.003. Epub 2022 Dec 13. J Allergy Clin Immunol Glob. 2023. PMID: 36532656 Free PMC article. Review.

See all "Cited by" articles

References

1. Gulen T., Hagglund H., Dahlen B., Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279:211–228. - PubMed
1. Gulen T., Hagglund H., Dahlen B., Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis—a single-centre experience. Clin Exp Allergy. 2014;44:121–129. - PubMed
1. Zanoni G., Zanotti R., Schena D., Sabbadini C., Opri R., Bonadonna P. Vaccination management in children and adults with mastocytosis. Clin Exp Allergy. 2017;47:593–596. - PubMed
1. CDC COVID-19 Response Team, Food and Drug Administration Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:46–51. - PMC - PubMed
1. Kaakati R., Khokhar D., Akin C. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome. J Allergy Clin Immunol Pract. 2021;9:3198–3199. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- Genetic Alliance
- MedlinePlus Health Information

[1] Gulen T., Hagglund H., Dahlen B., Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279:211–228. - PubMed

[2] Gulen T., Hagglund H., Dahlen B., Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279:211–228. - PubMed

[3] Gulen T., Hagglund H., Dahlen B., Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis—a single-centre experience. Clin Exp Allergy. 2014;44:121–129. - PubMed

[4] Gulen T., Hagglund H., Dahlen B., Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis—a single-centre experience. Clin Exp Allergy. 2014;44:121–129. - PubMed

[5] Zanoni G., Zanotti R., Schena D., Sabbadini C., Opri R., Bonadonna P. Vaccination management in children and adults with mastocytosis. Clin Exp Allergy. 2017;47:593–596. - PubMed

[6] Zanoni G., Zanotti R., Schena D., Sabbadini C., Opri R., Bonadonna P. Vaccination management in children and adults with mastocytosis. Clin Exp Allergy. 2017;47:593–596. - PubMed

[7] CDC COVID-19 Response Team, Food and Drug Administration Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:46–51. - PMC - PubMed

[8] CDC COVID-19 Response Team, Food and Drug Administration Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70:46–51. - PMC - PubMed

[9] Kaakati R., Khokhar D., Akin C. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome. J Allergy Clin Immunol Pract. 2021;9:3198–3199. - PMC - PubMed

[10] Kaakati R., Khokhar D., Akin C. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome. J Allergy Clin Immunol Pract. 2021;9:3198–3199. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

Affiliations

COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical